2023
Digital biobanks are underutilized in dermatology and create opportunities to reduce the burden of skin disease
Jumonville G, Hong D, Khan A, DeWan A, Leal S, Weng C, Petukhova L. Digital biobanks are underutilized in dermatology and create opportunities to reduce the burden of skin disease. British Journal Of Dermatology 2023, 190: 566-568. PMID: 37936310, PMCID: PMC10941321, DOI: 10.1093/bjd/ljad439.Peer-Reviewed Original ResearchConceptsBurden of skin diseaseGenetic architectureDiscover genesGenetic dataGene-environment interactionsClinical areasBiobank dataHealth dataMedical careDisease mechanismsGlobal burdenDisease relationshipsMedical interventionsDrug repurposingPharmacogenetic relationshipBiobankSkin diseasesGlobal burden of skin diseaseGenesKnowledge promisesAdverse eventsCareDermatologyHealthDisease
2022
Escalation of Antithrombotic Therapy in Patients With Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization
Kim T, DeWan A, Murray M, Wang H, Mani A, Mena-Hurtado C, Guzman R, Chaar C. Escalation of Antithrombotic Therapy in Patients With Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization. Journal Of Vascular Surgery 2022, 75: e281. DOI: 10.1016/j.jvs.2022.03.640.Peer-Reviewed Original ResearchLower Extremity Revascularization Among Patients With Premature Peripheral Artery Disease Compared To Patients At The Common Age Of Presentation In The Vascular Quality Initiative
Kim T, Loh S, Dewan A, Murray M, Mojibian H, Mani A, Mena-Hurtado C, Chaar C. Lower Extremity Revascularization Among Patients With Premature Peripheral Artery Disease Compared To Patients At The Common Age Of Presentation In The Vascular Quality Initiative. Annals Of Vascular Surgery 2022, 79: 400-401. DOI: 10.1016/j.avsg.2021.12.049.Peer-Reviewed Original ResearchMajor adverse limb eventsLower extremity revascularizationPeripheral artery diseaseCommon ageExtremity revascularizationArtery diseaseAdverse limb eventsDe novo diseaseOutcomes of patientsVascular Quality InitiativeInsulin-dependent diabetesSevere disease burdenNovo diseaseTASC classificationConclusions PatientsPatient agePatients 60Poor outcomeDisease burdenSevere diseaseLimb eventsPatientsLogistic regressionOne-yearDisease